2024 annual financial data
Bone Biologics 2024 Operating margin
Bone Biologics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -4,219,000 USD and net income was -4,112,000 USD.
Operating cash flow was -4,124,935 USD.
Get free Bone Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -4,219,000 USD
- Net income
- -4,112,000 USD
- Operating cash flow
- -4,124,935 USD